Literature DB >> 19528989

Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population.

Soo Bong Lee1, Keizo Kanasaki, Raghu Kalluri.   

Abstract

Progressive renal fibrosis is common to all chronic kidney diseases (CKD). Suthanthiran and colleagues identified a positive association between transforming growth factor-beta1 and several risk factors for CKD progression in African Americans but not in whites. This study offers a possible explanation for the higher prevalence of end-stage renal disease in African Americans and highlights the need for a better therapeutic strategy for this population.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19528989      PMCID： PMC4313549          DOI： 10.1038/ki.2009.130

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  18 in total

Review 1.  Angiotensin II, TGF-beta and renal fibrosis.

Authors:  J Gaedeke; H Peters; N A Noble; W A Border
Journal:  Contrib Nephrol       Date:  2001       Impact factor: 1.580

2.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.

Authors:  L G Hunsicker; S Adler; A Caggiula; B K England; T Greene; J W Kusek; N L Rogers; P E Teschan
Journal:  Kidney Int       Date:  1997-06       Impact factor: 10.612

3.  Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats.

Authors:  Philippe Lavoie; Geneviève Robitaille; Mohsen Agharazii; Steve Ledbetter; Marcel Lebel; Richard Larivière
Journal:  J Hypertens       Date:  2005-10       Impact factor: 4.844

4.  Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients.

Authors:  M Suthanthiran; A Khanna; D Cukran; R Adhikarla; V K Sharma; T Singh; P August
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

Review 5.  Mechanisms of kidney fibrosis and the role of antifibrotic therapies.

Authors:  Leo Deelman; Kumar Sharma
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

6.  Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; John W Kusek; Julia B Lewis; Xuelei Wang; Michael S Lipkowitz; Keith C Norris; George L Bakris; Mahboob Rahman; Gabriel Contreras; Stephen G Rostand; Joel D Kopple; Francis B Gabbai; Gerald I Schulman; Jennifer J Gassman; Jeanne Charleston; Lawrence Y Agodoa
Journal:  Arch Intern Med       Date:  2008-04-28

Review 7.  TGF-beta in renal injury and disease.

Authors:  Erwin P Böttinger
Journal:  Semin Nephrol       Date:  2007-05       Impact factor: 5.299

Review 8.  Renal risk scores: progress and prospects.

Authors:  M W Taal; B M Brenner
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

9.  Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

Authors:  M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

Authors:  Y Huang; N A Noble; J Zhang; C Xu; W A Border
Journal:  Kidney Int       Date:  2007-03-28       Impact factor: 18.998
View more
  7 in total

1.  Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.

Authors:  Dong Zhou; Yuan Tian; Ling Sun; Lili Zhou; Liangxiang Xiao; Roderick J Tan; Jianwei Tian; Haiyan Fu; Fan Fan Hou; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2016-09-13       Impact factor: 10.121

2.  HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.

Authors:  Marta E Bull; Jillian Legard; Kenneth Tapia; Bess Sorensen; Susan E Cohn; Rochelle Garcia; Sarah E Holte; Robert W Coombs; Jane E Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

3.  Feature selection and classification of urinary mRNA microarray data by iterative random forest to diagnose renal fibrosis: a two-stage study.

Authors:  Le-Ting Zhou; Yu-Han Cao; Lin-Li Lv; Kun-Ling Ma; Ping-Sheng Chen; Hai-Feng Ni; Xiang-Dong Lei; Bi-Cheng Liu
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

Review 4.  TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases.

Authors:  Philip Chiu-Tsun Tang; Alex Siu-Wing Chan; Cai-Bin Zhang; Cristina Alexandra García Córdoba; Ying-Ying Zhang; Ka-Fai To; Kam-Tong Leung; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Front Med (Lausanne)       Date:  2021-02-25

5.  A functional TGFB1 polymorphism in the donor associates with long-term graft survival after kidney transplantation.

Authors:  Felix Poppelaars; Mariana Gaya da Costa; Bernardo Faria; Siawosh K Eskandari; Jeffrey Damman; Marc A Seelen
Journal:  Clin Kidney J       Date:  2021-09-17

6.  Extracranial arteriovenous malformations demonstrate dysregulated TGF-β/BMP signaling and increased circulating TGF-β1.

Authors:  Ting Wei; Gresham T Richter; Haihong Zhang; Ravi W Sun; Conor H Smith; Graham M Strub
Journal:  Sci Rep       Date:  2022-10-05       Impact factor: 4.996

7.  Role of TGF-β in a mouse model of high turnover renal osteodystrophy.

Authors:  Shiguang Liu; Wenping Song; Joseph H Boulanger; Wen Tang; Yves Sabbagh; Brian Kelley; Russell Gotschall; Susan Ryan; Lucy Phillips; Katie Malley; Xiaohong Cao; Tai-He Xia; Gehua Zhen; Xu Cao; Hong Ling; Paul C Dechow; Teresita M Bellido; Steven R Ledbetter; Susan C Schiavi
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.